Skip to content

kidilact effect on stomach infection

Comparison between therapy regimen of amoxicillin,omeperazole,metronidazole and therapy regimen of amoxicillin,omeperazole,metronidazole and kidilact for treatment of helicobacter pylori infection in children 5 to 18 years in Imam Ali clinic of Shahrekord

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017051433965N1
Enrollment
65
Registered
2017-07-05
Start date
2017-07-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori infection of stomach. Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters

Interventions

Intervention 1: Therapy regimen of amoxicillin,omeperazole,metronidazole in control group. Intervention 2: Therapy regimen of amoxicillin,omeperazole,metronidazole and kidilact in intervention group.
Treatment - Drugs
Therapy regimen of amoxicillin,omeperazole,metronidazole in control group
Therapy regimen of amoxicillin,omeperazole,metronidazole and kidilact in intervention group

Sponsors

Zahedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 18 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: patients younger than 18 years old that are referred to Imam Ali clinic of Shahrekord because of gastrointestinal problems and have under gone endoscopy and Helicobacter Pylori is approved with rapid urease test, pathology or stool antigen ; Patients having gastrointestinal problems who have written consent for inclusion after receiving a full explanation of the treatment, drugs used, duration of treatment and possible side effects Exclusion criteria: Patients who have allergy to any of the medications amoxicillin, omeprazole, metronidazole, kidilact ; Patients who experience complications such as severe or unbearable pain ,severe vomiting during study ; Patients who want to leave the study for any reason during the study; patients who previously were treated with Helicobacter pylori eradication regimen; The recent use of probiotics, antibiotics, anti-acid

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Helicobacter pylori eradication rate. Timepoint: 2 weeks after end of treatment. Method of measurement: Stool antigen Test.

Secondary

MeasureTime frame
Therapy side effects rate. Timepoint: Day 14 of treatment, 2 weeks after completion of antibiotic therapy and 4 to 6 weeks after completion of antibiotic therapy. Method of measurement: Check list that is completed by parents include diarrhea, constipation, nausea, vomiting, abdominal pain, heartburn, early satiety, decreased appetite, belching, metallic taste in mouth, halitosis and hives.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDoctor Karam Ali Kasiri

Shahrekord University of Medical Sciences

kasiri2007@yahoo.com+98 38 3334 3701

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026